Last reviewed · How we verify

NCT03533426

Ultrasound-guided Serratus Block and the Emergence of Post-thoracotomy Pain Syndrome

Completed NA Last updated 17 July 2018
What this trial tests

NA trial testing Serratus anterior plane catheter block in Thoracic Neuritis in 90 participants. Completed in 15 July 2018.

Timeline
27 March 2018
Primary endpoint
15 July 2018
15 July 2018

Quick facts

Lead sponsorNational Cancer Institute, Egypt
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment90
Start date27 March 2018
Primary completion15 July 2018
Estimated completion15 July 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

National Cancer Institute, Egypt

Who can join

18 and older, any sex, with Thoracic Neuritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this prospective, single blinded, comparative pilot study is to evaluate U/S guided serratus anterior plane catheter block (SAPB) versus patient-controlled analgesia (PCA) on the emergence of post - thoracotomy pain syndrome (PTPS). The investigator's assumed hypothesis is that; SAPB is an effective thoracic analgesic technique that may reduce the development of PTPS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other National Cancer Institute, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing